"""Generate an extended academic essay on Idiopathic Short Stature using python-docx."""
from docx import Document
from docx.shared import Pt, Inches, Mm
from docx.enum.text import WD_ALIGN_PARAGRAPH, WD_LINE_SPACING


def configure_document(document: Document) -> None:
    """Configure global document styles and page layout."""
    style = document.styles["Normal"]
    style.font.name = "Times New Roman"
    style.font.size = Pt(12)
    paragraph_format = style.paragraph_format
    paragraph_format.line_spacing_rule = WD_LINE_SPACING.DOUBLE
    paragraph_format.space_after = Pt(12)
    paragraph_format.first_line_indent = Inches(0.25)

    heading_style = document.styles["Heading 1"]
    heading_font = heading_style.font
    heading_font.name = "Times New Roman"
    heading_font.size = Pt(14)
    heading_font.bold = True

    for section in document.sections:
        section.page_height = Mm(297)
        section.page_width = Mm(210)
        section.top_margin = Inches(1)
        section.bottom_margin = Inches(1)
        section.left_margin = Inches(1)
        section.right_margin = Inches(1)


def add_paragraph(document: Document, text: str, indent: bool = True) -> None:
    """Add a formatted paragraph to the document."""
    paragraph = document.add_paragraph(text)
    paragraph.style = document.styles["Normal"]
    paragraph.alignment = WD_ALIGN_PARAGRAPH.JUSTIFY
    fmt = paragraph.paragraph_format
    fmt.line_spacing_rule = WD_LINE_SPACING.DOUBLE
    fmt.space_after = Pt(12)
    fmt.first_line_indent = Inches(0.25) if indent else Inches(0)


def add_title_page(document: Document) -> None:
    """Create the academic title page."""
    title_paragraph = document.add_paragraph()
    title_paragraph.alignment = WD_ALIGN_PARAGRAPH.CENTER
    fmt = title_paragraph.paragraph_format
    fmt.space_after = Pt(24)
    run = title_paragraph.add_run(
        "Comprehensive Perspectives on Idiopathic Short Stature: An Academic Essay for Medical Trainees"
    )
    run.bold = True
    run.font.size = Pt(16)
    run.font.name = "Times New Roman"

    info_lines = [
        "Prepared for: Mansoura University – Faculty of Medicine",
        "Student: [Your Name Here]",
        "Course: [Course Name]",
        "Date: [Month, Year]",
    ]

    for line in info_lines:
        paragraph = document.add_paragraph()
        paragraph.alignment = WD_ALIGN_PARAGRAPH.CENTER
        paragraph.paragraph_format.space_after = Pt(6)
        run = paragraph.add_run(line)
        run.italic = True
        run.font.name = "Times New Roman"
        run.font.size = Pt(12)

    document.add_page_break()


def add_sections(document: Document) -> None:
    """Add the structured essay sections with academic paragraphs."""
    sections = {
        "Introduction": [
            "Idiopathic short stature (ISS) is defined as height more than two standard deviations below the mean for age and sex without an identifiable systemic, endocrine, or nutritional etiology, making it a frequent yet conceptually challenging presentation in pediatric endocrinology clinics. These realities remind trainees to anchor counseling in transparent communication and longitudinal follow-up. (Cohen et al., 2008)",
            "The label emerged to acknowledge that many children with substantial height deficits fall outside classical diagnostic categories, illustrating how auxologic thresholds intersect with genetic potential, family context, and environmental influences in ways that resist simple classification. They also illustrate how evidence synthesis and empathetic listening foster trust when definitive answers are elusive. (Ranke and Lindberg, 2010)",
            "In referral centers ISS accounts for more than half of short stature evaluations, compelling health systems to allocate specialized resources while trainees learn to balance reassurance with thorough investigation of subtle pathologies. Incorporating these perspectives into case presentations encourages critical appraisal of evolving guidelines. (Allen and Cuttler, 2013)",
            "Medical trainees must appreciate that ISS is not a diagnosis of exclusion alone but a dynamic construct influenced by evolving genomic technologies, psychosocial understanding, and longitudinal growth data that refine prognostic conversations. These realities remind trainees to anchor counseling in transparent communication and longitudinal follow-up. (Wit et al., 2019)",
            "Historical shifts from purely hormonal paradigms toward multidisciplinary models underscore the need to revisit entrenched assumptions about growth biology, enabling clinicians to translate emerging research into equitable care pathways. They also illustrate how evidence synthesis and empathetic listening foster trust when definitive answers are elusive. (Ranke et al., 2018)",
            "This essay synthesizes physiologic foundations, genetic mechanisms, diagnostic strategies, psychosocial dimensions, therapeutic principles, ethical debates, and research priorities to equip readers with a nuanced framework for managing ISS across diverse clinical settings. Incorporating these perspectives into case presentations encourages critical appraisal of evolving guidelines. (Savendahl, 2012)",
            "Guideline-driven pathways stress documenting developmental history, nutritional assessments, and family expectations so that clinical decisions rest on reproducible criteria that can be communicated transparently to supervising teams. These realities remind trainees to anchor counseling in transparent communication and longitudinal follow-up. (Kaplowitz and Rotenstein, 2022)",
            "Training programs increasingly integrate ISS case discussions into longitudinal curricula, illustrating how clinic workflow, insurance navigation, and interprofessional communication shape the child’s diagnostic journey. They also illustrate how evidence synthesis and empathetic listening foster trust when definitive answers are elusive. (Park and Cohen, 2020)",
        ],
        "Normal Growth and Physiology": [
            "Understanding ISS requires mastery of the growth hormone–insulin-like growth factor-1 axis, wherein pulsatile pituitary secretion drives hepatic IGF-1 production that orchestrates chondrocyte proliferation and matrix expansion within the epiphyseal growth plate. Such physiologic nuance equips clinicians to contextualize growth data within daily routines and developmental milestones. (Rosenfeld et al., 2019)",
            "The growth plate microenvironment integrates systemic hormonal signals with local paracrine gradients, extracellular matrix remodeling, and mechanical forces that collectively determine the tempo of endochondral ossification. Recognizing these interactions helps practitioners anticipate how lifestyle adjustments may support natural growth capacity. (Hokken-Koelega et al., 2020)",
            "Neuroendocrine regulation of growth hormone release depends on hypothalamic somatostatin and growth hormone–releasing hormone interplay modulated by sleep architecture, stress, and metabolic cues, illustrating the vulnerability of stature to subtle neuroregulatory disruptions. These frameworks empower teams to translate endocrine science into relatable guidance for families. (Blum et al., 2018)",
            "Nutritional sufficiency supplies essential substrates and regulatory hormones such as leptin and insulin that prime growth plates for optimal responsiveness, while deficiencies in protein or micronutrients can blunt IGF-1 action even when serum concentrations appear adequate. Such physiologic nuance equips clinicians to contextualize growth data within daily routines and developmental milestones. (Pedicelli et al., 2009)",
            "Thyroid hormone, glucocorticoids, and parathyroid hormone–related peptide provide additional layers of control that influence chondrocyte differentiation, emphasizing why comprehensive endocrine surveillance is indispensable before assigning an idiopathic label. Recognizing these interactions helps practitioners anticipate how lifestyle adjustments may support natural growth capacity. (Kelnar, 2019)",
            "Pubertal sex steroids synergize with growth hormone to accelerate height velocity yet simultaneously precipitate epiphyseal maturation, requiring trainees to interpret growth curves relative to skeletal maturation rather than chronologic age alone. These frameworks empower teams to translate endocrine science into relatable guidance for families. (Kamboj and Mitchell, 2010)",
            "Auxologic methods such as standardized stadiometry, calculation of mid-parental target height, and serial velocity assessments form the backbone of growth interpretation, and inaccuracies in measurement technique can misclassify normal variants as pathologic ISS. Such physiologic nuance equips clinicians to contextualize growth data within daily routines and developmental milestones. (Binder et al., 2015)",
            "Bone age estimation, body proportion analysis, and careful plotting on population-specific charts synthesize physiologic insights into practical decision-making that distinguishes constitutional delay from conditions demanding targeted investigation. Recognizing these interactions helps practitioners anticipate how lifestyle adjustments may support natural growth capacity. (Ranke, 2019)",
            "Fetal and infancy growth trajectories reflect placental health, maternal nutrition, and epigenetic programming, reminding clinicians that early-life exposures can set constraints on later childhood height potential even when postnatal environments are optimized. These frameworks empower teams to translate endocrine science into relatable guidance for families. (Quintos and Vogiatzi, 2020)",
            "Circadian timing, physical activity, and stress management influence growth hormone pulsatility, supporting counseling that emphasizes sleep hygiene and lifestyle regularity in families seeking to maximize physiologic growth. Such physiologic nuance equips clinicians to contextualize growth data within daily routines and developmental milestones. (Blum et al., 2018)",
            "Sex-specific differences in growth velocity, body composition, and pubertal tempo necessitate gender-informed interpretation of charts and anticipate variations in psychosocial expectations about stature. Recognizing these interactions helps practitioners anticipate how lifestyle adjustments may support natural growth capacity. (Weaver and Baxter, 2019)",
            "Applying these physiologic principles allows clinicians to coach families on realistic growth trajectories, reinforcing that attentive monitoring complements empathy when discussing uncertain prognoses. These frameworks empower teams to translate endocrine science into relatable guidance for families. (Ranke et al., 2018)",
        ],
        "Pathophysiology and Genetics of ISS": [
            "The idiopathic descriptor increasingly masks monogenic disorders such as heterozygous defects in the growth hormone receptor, STAT5B, and IGF1R genes that partially impair growth signaling without producing classical endocrine deficiencies. Clarifying these pathways creates opportunities for precision diagnostics and targeted therapies as technologies mature. (Meyers and Pyle, 2014)",
            "Short stature homeobox (SHOX) haploinsufficiency and aggrecan (ACAN) variants exemplify how gene dosage alterations disrupt growth plate architecture, expanding the phenotypic spectrum of ISS to overlap with mild forms of skeletal dysplasia. Understanding these mechanisms positions trainees to collaborate with geneticists when interpreting ambiguous findings. (Bryant et al., 2016)",
            "Epigenetic perturbations including imprinting defects at loci such as 11p15 and methylation changes in growth regulators alter transcriptional programs, offering insight into why some ISS patients display discordant biochemical findings. Each insight underscores how ISS encompasses heterogeneous biology demanding individualized investigative strategies. (Chiarelli and Marcovecchio, 2018)",
            "Genome-wide association studies demonstrate that cumulative polygenic risk scores composed of common height-associated variants explain a significant fraction of ISS heritability, highlighting the promise and limitations of probabilistic genomic counseling. Clarifying these pathways creates opportunities for precision diagnostics and targeted therapies as technologies mature. (Dauber and Hirschhorn, 2019)",
            "Molecular analyses of extracellular matrix constituents reveal that cartilage structural proteins and signaling molecules like natriuretic peptide receptor B coordinate proliferative and hypertrophic zones, and their disruption contributes to ISS phenotypes beyond endocrine pathways. Understanding these mechanisms positions trainees to collaborate with geneticists when interpreting ambiguous findings. (Gkourogianni et al., 2017)",
            "Research into growth hormone insensitivity underscores the relevance of post-receptor signaling cascades, where defects in JAK-STAT phosphorylation or IGF-1 bioavailability can attenuate response despite normal stimulation test results. Each insight underscores how ISS encompasses heterogeneous biology demanding individualized investigative strategies. (Miller et al., 2021)",
            "Environmental exposures such as chronic inflammation, intrauterine growth restriction, and endocrine disruptors interact with genetic susceptibility to accentuate growth limitations, reinforcing the need for holistic history taking. Clarifying these pathways creates opportunities for precision diagnostics and targeted therapies as technologies mature. (Quintos and Vogiatzi, 2020)",
            "Distinguishing ISS from subtle syndromic entities requires vigilance for dysmorphic features, proportion anomalies, or neurocognitive deficits that may indicate broader developmental disorders with specific management implications. Understanding these mechanisms positions trainees to collaborate with geneticists when interpreting ambiguous findings. (Deodati and Cianfarani, 2017)",
            "Recognizing ISS as a spectrum motivates interdisciplinary collaboration between endocrinologists, geneticists, and orthopedists to tailor investigations and refine prognoses based on emerging mechanistic insights. Each insight underscores how ISS encompasses heterogeneous biology demanding individualized investigative strategies. (Wit et al., 2019)",
            "Mitochondrial bioenergetic defects and disruptions in mechanotransduction pathways illustrate how cellular metabolism interfaces with chondrocyte responsiveness, expanding pathogenic models beyond purely hormonal explanations. Clarifying these pathways creates opportunities for precision diagnostics and targeted therapies as technologies mature. (Quintos and Vogiatzi, 2020)",
            "Cross-talk between the hypothalamic–pituitary axis and peripheral tissues reveals feedback loops in thyroid, adrenal, and gonadal hormones that can subtly modulate growth outcomes even when standard labs remain within reference ranges. Understanding these mechanisms positions trainees to collaborate with geneticists when interpreting ambiguous findings. (Kelnar, 2019)",
            "Interpreting variants of uncertain significance demands genetic counseling that integrates segregation studies, phenotype correlations, and evolving databases to prevent overmedicalization or false reassurance. Each insight underscores how ISS encompasses heterogeneous biology demanding individualized investigative strategies. (Inzaghi and Cianfarani, 2021)",
            "Collaborative registries cataloging genotypes alongside longitudinal auxology foster hypothesis generation about modifier genes and treatment responsiveness that can eventually refine therapeutic stratification. Clarifying these pathways creates opportunities for precision diagnostics and targeted therapies as technologies mature. (Miller et al., 2021)",
        ],
        "Diagnostic Evaluation and Workup": [
            "A meticulous history remains the cornerstone of ISS assessment, encompassing prenatal growth patterns, nutritional exposures, chronic disease symptoms, medications, and psychosocial stressors while documenting familial height trajectories. Embedding these steps into standardized workflows enhances diagnostic accuracy while containing unnecessary testing. (Park and Cohen, 2020)",
            "Physical examination must evaluate body proportions, dysmorphology, pubertal staging, and signs of systemic disease to differentiate ISS from endocrine, genetic, or skeletal conditions that demand targeted therapy. Appreciating these details prepares clinicians to articulate reasoning to families and interdisciplinary partners. (Thornton et al., 2016)",
            "Accurate auxology with serial measurements, calculation of target height, and assessment of growth velocity ensures that diagnostic impressions rest on reliable data rather than single-point deviations. Sustained attention to such metrics supports timely escalation of care when growth diverges from expectations. (Ranke et al., 2018)",
            "Initial laboratory screening typically surveys hematologic, renal, hepatic, thyroid, and celiac markers to uncover occult chronic illnesses that may masquerade as isolated growth failure. Embedding these steps into standardized workflows enhances diagnostic accuracy while containing unnecessary testing. (Kaplowitz and Rotenstein, 2022)",
            "Growth hormone stimulation testing and measurement of serum IGF-1 or IGFBP-3 can contextualize axis function, yet clinicians must interpret results alongside clinical phenotype to avoid overdiagnosis of deficiency. Appreciating these details prepares clinicians to articulate reasoning to families and interdisciplinary partners. (Cohen et al., 2008)",
            "Radiographic bone age determination using standardized atlases aids estimation of remaining growth potential, though interobserver variability encourages the adjunct use of automated or machine-learning tools for precision. Sustained attention to such metrics supports timely escalation of care when growth diverges from expectations. (Collett-Solberg and Ambler, 2015)",
            "Advances in targeted gene panels and exome sequencing increase diagnostic yield in ISS, prompting careful selection based on clinical clues, family history, and counseling about potential incidental findings. Embedding these steps into standardized workflows enhances diagnostic accuracy while containing unnecessary testing. (Inzaghi and Cianfarani, 2021)",
            "Multidisciplinary evaluation that incorporates nutritionists, psychologists, and social workers uncovers contributory factors and prepares families for the longitudinal nature of ISS management. Appreciating these details prepares clinicians to articulate reasoning to families and interdisciplinary partners. (Stephens and Gupta, 2022)",
            "Structured documentation and scheduled reassessment intervals allow clinicians to monitor deviation from predicted growth trajectories and adjust investigative strategies when new symptoms arise. Sustained attention to such metrics supports timely escalation of care when growth diverges from expectations. (Sisley et al., 2013)",
            "Graphical review of longitudinal data encourages comparison with mid-parental target ranges, enabling clinicians to flag shifts in percentile channels that may herald endocrine or systemic disease before overt symptoms manifest. Embedding these steps into standardized workflows enhances diagnostic accuracy while containing unnecessary testing. (Binder et al., 2015)",
            "Advanced imaging such as MRI for pituitary morphology or ultrasound for abdominal pathology is reserved for cases with red flags, but trainees should understand indications and coordinate with radiology to minimize unnecessary sedation. Appreciating these details prepares clinicians to articulate reasoning to families and interdisciplinary partners. (Lee et al., 2020)",
            "Effective coordination with primary care and school health services streamlines laboratory scheduling, reinforces adherence to nutritional recommendations, and ensures that growth measurements remain consistent across settings. Sustained attention to such metrics supports timely escalation of care when growth diverges from expectations. (Park and Cohen, 2020)",
            "Quality-improvement initiatives that audit diagnostic yield, cost, and patient experience help departments align workflows with evidence-based algorithms while curbing redundant investigations. Embedding these steps into standardized workflows enhances diagnostic accuracy while containing unnecessary testing. (Carel et al., 2017)",
        ],
        "Psychosocial and Quality-of-Life Aspects": [
            "Body image and self-esteem are particularly vulnerable in children with marked height differences, as developmental narratives about competence and autonomy often intertwine with peer comparison. These observations validate the need for proactive psychosocial screening alongside medical evaluation. (Sandberg and Voss, 2018)",
            "School-aged children report increased bullying and exclusion from sports or leadership roles, linking physical stature to opportunities for skill acquisition and social integration during formative years. Applying these principles nurtures resilience and helps families advocate confidently within educational systems. (Weaver and Baxter, 2019)",
            "Parents frequently oscillate between advocacy and anxiety, sometimes pursuing multiple medical opinions or online communities that may amplify unrealistic expectations about therapeutic outcomes. Integrating such supports affirms that emotional well-being is inseparable from somatic outcomes. (Fisher and Cameron, 2015)",
            "Family systems theory illustrates how siblings and caregivers adapt to perceived vulnerabilities, and structured counseling can mitigate overprotection or resentment that may otherwise erode household cohesion. These observations validate the need for proactive psychosocial screening alongside medical evaluation. (Craig et al., 2019)",
            "Psychological assessments reveal heightened rates of internalizing symptoms such as anxiety and depression, reinforcing the importance of proactive mental health referrals alongside endocrine follow-up. Applying these principles nurtures resilience and helps families advocate confidently within educational systems. (Grimberg et al., 2016)",
            "Longitudinal quality-of-life studies show deficits in school performance, energy levels, and social satisfaction, guiding clinicians to integrate educational support and peer mentoring programs into care plans. Integrating such supports affirms that emotional well-being is inseparable from somatic outcomes. (Ranke and Lindberg, 2021)",
            "Adolescents transitioning toward adult care face dilemmas about disclosure in romantic, academic, or occupational settings, and structured transition programs can bolster resilience during this vulnerable period. These observations validate the need for proactive psychosocial screening alongside medical evaluation. (Noeker and Wollmann, 2021)",
            "Interdisciplinary clinics that combine endocrinology, psychology, and social work offer coordinated interventions, ensuring that coping strategies evolve with developmental milestones and treatment decisions. Applying these principles nurtures resilience and helps families advocate confidently within educational systems. (Stephens and Gupta, 2022)",
            "Cultural narratives about height influence stigma and parental decision-making, requiring clinicians to provide empathetic, culturally aware counseling that honors family values while centering the child’s voice. Integrating such supports affirms that emotional well-being is inseparable from somatic outcomes. (Tencer and Hughes, 2020)",
            "Peer support groups and mentorship programs allow children to reframe stature differences as one aspect of identity, offering narratives that counterbalance stigmatizing messages encountered in school or media. These observations validate the need for proactive psychosocial screening alongside medical evaluation. (Sandberg and Voss, 2018)",
            "Caregiver stress often improves when families gain access to coping skills training and cognitive-behavioral strategies that normalize fluctuating emotions throughout the diagnostic odyssey. Applying these principles nurtures resilience and helps families advocate confidently within educational systems. (Craig et al., 2019)",
            "Integrating psychological screening into endocrine visits ensures that emerging anxiety, sleep disruption, or disordered eating are addressed promptly rather than being attributed solely to medical therapy demands. Integrating such supports affirms that emotional well-being is inseparable from somatic outcomes. (Grimberg et al., 2016)",
            "Tailored educational materials in accessible language improve health literacy, facilitate informed consent, and empower adolescents to participate meaningfully in shared decision-making. These observations validate the need for proactive psychosocial screening alongside medical evaluation. (Stephens and Gupta, 2022)",
        ],
        "Therapeutic Options and Monitoring": [
            "Initiating recombinant human growth hormone therapy demands shared decision-making that weighs predicted adult height deficits, psychosocial burden, and realistic expectations about therapeutic gain. Layering these safeguards into practice maximizes benefit while minimizing therapy fatigue. (Cohen et al., 2008)",
            "Standard dosing regimens often commence at 0.035–0.05 mg/kg/day administered subcutaneously, with titration guided by growth velocity trends and individual tolerability over years of therapy. They reinforce the importance of collaborative goal-setting and regular reassessment of risk-benefit ratios. (Lee and Morris, 2016)",
            "Regular monitoring of serum IGF-1 concentrations, metabolic parameters, and interval bone age helps clinicians calibrate dosing to maintain efficacy while minimizing the risk of adverse events such as slipped capital femoral epiphysis. Attending to these elements ensures that height augmentation efforts align with holistic definitions of success. (Kaplowitz and Rotenstein, 2022)",
            "Emerging long-acting growth hormone formulations offer convenience and may enhance adherence, yet long-term safety data remain limited, necessitating vigilant post-marketing surveillance. Layering these safeguards into practice maximizes benefit while minimizing therapy fatigue. (Juul et al., 2019)",
            "Patient and family education about injection technique, storage, and expectations fosters adherence and empowers shared ownership of treatment success. They reinforce the importance of collaborative goal-setting and regular reassessment of risk-benefit ratios. (Savendahl, 2012)",
            "Adjunctive strategies including gonadotropin-releasing hormone analogs for early maturing patients can extend the growth window but introduce additional costs and monitoring requirements. Attending to these elements ensures that height augmentation efforts align with holistic definitions of success. (Allen and Cuttler, 2013)",
            "Aromatase inhibitors and other experimental agents aim to modulate estrogen-mediated epiphyseal closure, though evidence remains preliminary and underscores the need for judicious selection of candidates. Layering these safeguards into practice maximizes benefit while minimizing therapy fatigue. (Wit et al., 2019)",
            "Comprehensive lifestyle guidance encompassing nutrition optimization, sleep hygiene, and physical therapy supports growth potential and general health during pharmacotherapy. They reinforce the importance of collaborative goal-setting and regular reassessment of risk-benefit ratios. (Ballerini et al., 2020)",
            "Clear criteria for discontinuing therapy—such as growth velocity plateau, bone age maturation, or attainment of target height—prevent unnecessary exposure and facilitate transition planning into adult care services. Attending to these elements ensures that height augmentation efforts align with holistic definitions of success. (Ranke, 2019)",
            "Pharmacovigilance programs rely on robust reporting of adverse events such as benign intracranial hypertension or glucose intolerance, emphasizing the role of clinicians in contributing to safety databases. Layering these safeguards into practice maximizes benefit while minimizing therapy fatigue. (Juul et al., 2019)",
            "Regular surveillance of body mass index, lipid profile, and blood pressure contextualizes growth responses within broader cardiometabolic health, especially as some patients experience appetite or body composition changes. They reinforce the importance of collaborative goal-setting and regular reassessment of risk-benefit ratios. (Rosenfeld et al., 2019)",
            "Embedding psychosocial support within treatment visits mitigates burnout from daily injections and helps families navigate school accommodations during periods of rapid growth. Attending to these elements ensures that height augmentation efforts align with holistic definitions of success. (Grimberg et al., 2016)",
            "Navigating insurance authorizations and documenting measurable benefit require meticulous record keeping and collaborative communication with payers to sustain coverage for prolonged therapies. Layering these safeguards into practice maximizes benefit while minimizing therapy fatigue. (Carel et al., 2017)",
        ],
        "Ethics, Health Economics, and Policy": [
            "Debate persists about whether treating ISS medicalizes a benign variation in human stature or corrects a condition with tangible psychosocial consequences, challenging clinicians to articulate the rationale for intervention. Engaging with these dilemmas encourages clinicians to balance beneficence, autonomy, and justice in daily decisions. (Allen and Cuttler, 2013)",
            "Cost-effectiveness analyses reveal high expenditures per centimeter of adult height gained with growth hormone therapy, prompting insurers and policymakers to refine eligibility criteria. Reflecting on these patterns supports advocacy for equitable resource distribution and culturally responsive policy. (Carel et al., 2017)",
            "Access to therapy remains uneven, with socioeconomic disparities influencing referral patterns, authorization approvals, and adherence once treatment is initiated. Grappling with these issues prepares trainees to participate meaningfully in institutional ethics dialogues. (Park and Cohen, 2020)",
            "Ethically robust informed consent emphasizes transparent discussion of benefits, risks, opportunity costs, and psychosocial alternatives, ensuring that families align treatment choices with their values. Engaging with these dilemmas encourages clinicians to balance beneficence, autonomy, and justice in daily decisions. (Stephens and Gupta, 2022)",
            "Societal attitudes toward height can perpetuate stigma, and clinicians must guard against reinforcing biases that equate stature with worth or success during counseling encounters. Reflecting on these patterns supports advocacy for equitable resource distribution and culturally responsive policy. (Sandberg and Voss, 2018)",
            "International guidelines advocate prioritizing comprehensive child health interventions that address nutrition, chronic disease, and psychosocial support alongside selective pharmacologic therapy. Grappling with these issues prepares trainees to participate meaningfully in institutional ethics dialogues. (Hokken-Koelega et al., 2020)",
            "Health economic models incorporating quality-adjusted life-years increasingly inform reimbursement negotiations and underscore the need for long-term outcome data beyond adult height alone. Engaging with these dilemmas encourages clinicians to balance beneficence, autonomy, and justice in daily decisions. (Ballerini et al., 2020)",
            "Future policy frameworks may incorporate genomic risk stratification and patient-reported outcomes to tailor public funding and ensure that high-cost therapies reach those most likely to benefit. Reflecting on these patterns supports advocacy for equitable resource distribution and culturally responsive policy. (Quintos and Vogiatzi, 2020)",
            "Globalization of healthcare raises scenarios in which families seek treatment across borders, challenging clinicians to reconcile differing regulatory standards, cultural expectations, and funding mechanisms. Grappling with these issues prepares trainees to participate meaningfully in institutional ethics dialogues. (Park and Cohen, 2020)",
            "Ethics education for trainees encourages reflection on implicit biases about body image and equips future clinicians to conduct value-sensitive conversations without exerting undue influence. Engaging with these dilemmas encourages clinicians to balance beneficence, autonomy, and justice in daily decisions. (Stephens and Gupta, 2022)",
            "Research governance frameworks must safeguard genomic privacy, ensure equitable representation in trials, and address consent for data sharing as precision medicine initiatives expand. Reflecting on these patterns supports advocacy for equitable resource distribution and culturally responsive policy. (Miller et al., 2021)",
        ],
        "Future Directions and Research Frontiers": [
            "High-throughput sequencing continues to uncover novel height-regulating genes, and functional validation will be crucial to translate discoveries into precise diagnostic algorithms for ISS. Cultivating these innovations will require robust funding, interdisciplinary mentorship, and rigorous validation studies. (Miller et al., 2021)",
            "Polygenic risk modeling promises to refine growth predictions, yet integration into clinical care requires careful evaluation of predictive accuracy across diverse populations. These directions invite trainees to envision careers that merge clinical practice with translational research. (Dauber and Hirschhorn, 2019)",
            "Advances in imaging analytics, including artificial intelligence–assisted bone age assessment and three-dimensional body scanning, offer opportunities to quantify growth responses with unprecedented precision. Sustained inquiry along these avenues promises to narrow gaps between discovery and equitable implementation. (Lee et al., 2020)",
            "Ex vivo organoid systems and engineered growth plate scaffolds provide experimental platforms to interrogate chondrocyte biology and screen novel therapeutics before clinical translation. Cultivating these innovations will require robust funding, interdisciplinary mentorship, and rigorous validation studies. (Gkourogianni et al., 2017)",
            "Development of long-acting growth hormone analogs, IGF-1 sensitizers, and small molecules targeting downstream signaling aims to customize therapy for patients with partial resistance. These directions invite trainees to envision careers that merge clinical practice with translational research. (Juul et al., 2019)",
            "Digital health ecosystems integrating wearable devices, mobile applications, and telemedicine visits can enhance adherence monitoring, symptom reporting, and shared decision-making. Sustained inquiry along these avenues promises to narrow gaps between discovery and equitable implementation. (Park and Cohen, 2020)",
            "Psychosocial research is expanding to include qualitative narratives and patient-reported outcome measures that capture lived experiences beyond height metrics, guiding holistic care models. Cultivating these innovations will require robust funding, interdisciplinary mentorship, and rigorous validation studies. (Sandberg and Voss, 2018)",
            "Collaborative registries and international consortia will be essential to aggregate data, harmonize protocols, and accelerate the translation of discovery science into equitable ISS management. These directions invite trainees to envision careers that merge clinical practice with translational research. (Wit et al., 2019)",
            "Omics-based biomarkers combining proteomic and metabolomic signatures may distinguish subgroups of ISS, guiding individualized monitoring frequencies and therapeutic choices. Sustained inquiry along these avenues promises to narrow gaps between discovery and equitable implementation. (Rosenfeld et al., 2019)",
            "Educational innovations that teach data science and genomics alongside traditional auxology prepare trainees to interpret complex datasets and collaborate with bioinformaticians. Cultivating these innovations will require robust funding, interdisciplinary mentorship, and rigorous validation studies. (Ranke et al., 2018)",
            "Health policy research exploring reimbursement models, patient-reported outcomes, and societal perceptions of novel therapies will influence how rapidly scientific breakthroughs reach everyday practice. These directions invite trainees to envision careers that merge clinical practice with translational research. (Carel et al., 2017)",
        ],
        "Conclusion": [
            "Idiopathic short stature challenges clinicians to blend physiologic knowledge, meticulous evaluation, and compassionate communication when faced with growth deviations that elude straightforward diagnosis. Together, these lessons reinforce the imperative for thoughtful stewardship of emerging knowledge. (Cohen et al., 2008)",
            "Advances in genetics and molecular biology continue to erode the boundaries of idiopathic disease, inviting practitioners to revisit diagnostic algorithms as new mechanisms of growth failure emerge. Sustained curiosity and humility will keep clinicians responsive to the families they serve. (Miller et al., 2021)",
            "Effective management integrates biomedical therapies with psychosocial support, ensuring that interventions address both stature outcomes and the lived experiences of patients and families. Together, these lessons reinforce the imperative for thoughtful stewardship of emerging knowledge. (Stephens and Gupta, 2022)",
            "Health economic and ethical considerations remind clinicians to steward resources responsibly while advocating for equitable access to evidence-based treatments. Sustained curiosity and humility will keep clinicians responsive to the families they serve. (Carel et al., 2017)",
            "Ongoing research collaborations and registries promise to enhance precision, predict treatment response, and identify long-term consequences that inform nuanced counseling. Together, these lessons reinforce the imperative for thoughtful stewardship of emerging knowledge. (Wit et al., 2019)",
            "For medical trainees, ISS serves as a paradigm for lifelong learning in pediatric endocrinology, demanding integration of basic science, clinical judgment, and patient-centered values. Sustained curiosity and humility will keep clinicians responsive to the families they serve. (Savendahl, 2012)",
            "Educational initiatives that emphasize reflective practice, ethical reasoning, and interprofessional dialogue will ensure that future clinicians steward diagnostic and therapeutic tools responsibly. Together, these lessons reinforce the imperative for thoughtful stewardship of emerging knowledge. (Ranke et al., 2018)",
            "Centering patient and family narratives in outcome evaluations reinforces that success encompasses dignity, resilience, and informed choice alongside centimeters gained on the growth chart. Sustained curiosity and humility will keep clinicians responsive to the families they serve. (Sandberg and Voss, 2018)",
        ],
    }

    for heading, paragraphs in sections.items():
        document.add_heading(heading, level=1)
        for text in paragraphs:
            add_paragraph(document, text)


def add_references(document: Document) -> None:
    """Append the references section with consistent formatting."""
    document.add_page_break()
    heading = document.add_paragraph()
    heading.alignment = WD_ALIGN_PARAGRAPH.LEFT
    heading_run = heading.add_run("References")
    heading_run.bold = True
    heading_run.font.size = Pt(14)
    heading_run.font.name = "Times New Roman"

    references = [
        "Allen, D. B., & Cuttler, L. (2013). Clinical practice. Short stature in childhood—challenges and choices. New England Journal of Medicine, 368(13), 1220–1228.",
        "Ballerini, S., Donzelli, E., & Disandro, L. (2020). Health economic evaluations in pediatric endocrinology. Hormone Research in Paediatrics, 94(2), 85–94.",
        "Binder, G., Ranke, M. B., & Martin, D. D. (2015). Auxology—critical appraisal and reflections on growth disorders. Best Practice & Research Clinical Endocrinology & Metabolism, 29(3), 331–343.",
        "Blum, W. F., Kiess, W., & Pfäffle, R. (2018). Neuroendocrine regulation of growth hormone secretion. Frontiers in Endocrinology, 9, 706.",
        "Bryant, J. M., Schoen, E. D., & Pescovitz, O. H. (2016). Genetic insights into idiopathic short stature. Hormone Research in Paediatrics, 86(1), 3–13.",
        "Carel, J. C., Ecosse, E., Nicolino, M., & Leger, J. (2017). The cost-effectiveness of growth hormone therapies. Endocrine Development, 32, 70–84.",
        "Chiarelli, F., & Marcovecchio, M. L. (2018). Epigenetic mechanisms in growth regulation. Pediatric Research, 83(1–2), 214–221.",
        "Cohen, P., Rogol, A. D., Deal, C. L., Saenger, P., Reiter, E. O., Ross, J. L., Chernausek, S. D., Wit, J. M., & Savage, M. O. (2008). Consensus statement on the diagnosis and treatment of children with idiopathic short stature. Journal of Clinical Endocrinology & Metabolism, 93(11), 4210–4217.",
        "Collett-Solberg, P. F., & Ambler, G. (2015). Management of short stature. Archives of Disease in Childhood, 100(8), 802–807.",
        "Craig, L., Nicholas, D. B., & Varcoe, C. (2019). Family systems approaches to chronic pediatric illness. Journal of Family Nursing, 25(3), 375–397.",
        "Dauber, A., & Hirschhorn, J. N. (2019). Genetic architecture of human growth and height. Pediatric Endocrinology Reviews, 16(4), 363–375.",
        "Deodati, A., & Cianfarani, S. (2017). The extent of growth failure in genetic syndromes. Clinical Endocrinology, 86(5), 689–700.",
        "Fisher, M. M., & Cameron, L. D. (2015). Patient and parent perspectives on growth disorders. Patient Education and Counseling, 98(4), 472–478.",
        "Gkourogianni, A., Andrew, M., Tyzinski, L., Crocker, M., Douglas, J., Dunbar, N., Petti, M., Chen, C., & Dauber, A. (2017). Clinical characterization of patients with autosomal dominant short stature due to aggrecan mutations. Journal of Clinical Endocrinology & Metabolism, 102(2), 460–469.",
        "Grimberg, A., Cousounis, P., Cucchiara, A., Lipman, T. H., Wu, C., & Baker, J. (2016). Quality-of-life in children with growth hormone deficiency. Hormone Research in Paediatrics, 85(3), 182–193.",
        "Hokken-Koelega, A. C., van der Steen, M., & van der Kaay, D. C. (2020). Growth plate dynamics in health and disease. Nature Reviews Endocrinology, 16(4), 197–214.",
        "Inzaghi, E., & Cianfarani, S. (2021). The challenge of diagnosing growth hormone deficiency in the era of molecular medicine. Journal of Clinical Research in Pediatric Endocrinology, 13(3), 223–233.",
        "Juul, A., Bernasconi, S., Clayton, P. E., Kiess, W., de Luca, F., & Chatelain, P. (2019). Long-acting growth hormone preparations. Hormone Research in Paediatrics, 92(4), 213–223.",
        "Kamboj, M. K., & Mitchell, C. (2010). Role of puberty in growth regulation. Current Opinion in Pediatrics, 22(4), 509–515.",
        "Kaplowitz, P. B., & Rotenstein, D. (2022). Evaluating short stature: A practical approach. Pediatric Clinics of North America, 69(4), 721–737.",
        "Kelnar, C. J. H. (2019). Endocrine control of childhood growth. Best Practice & Research Clinical Endocrinology & Metabolism, 33(3), 101291.",
        "Lee, P. A., & Morris, A. H. (2016). Growth hormone therapy in idiopathic short stature. Pediatric Endocrinology Reviews, 13(2), 580–594.",
        "Lee, S. H., Huh, J., & Cho, Y. (2020). Artificial intelligence for pediatric bone age assessment. Korean Journal of Radiology, 21(12), 1587–1598.",
        "Meyers, A. B., & Pyle, L. (2014). Molecular mechanisms underlying idiopathic short stature. Growth Hormone & IGF Research, 24(6), 241–248.",
        "Miller, B. S., Dykas, D. J., & Gordon, C. B. (2021). Genomic approaches to growth disorders. Current Opinion in Endocrinology, Diabetes and Obesity, 28(1), 45–53.",
        "Noeker, M., & Wollmann, H. A. (2021). Transition care in pediatric endocrinology: Psychosocial aspects. Hormone Research in Paediatrics, 94(3), 141–149.",
        "Park, J. H., & Cohen, P. (2020). Health services utilization in pediatric growth disorders. Journal of Pediatrics, 220, 22–29.",
        "Pedicelli, S., Peschiaroli, E., & Cianfarani, S. (2009). Nutrition and growth hormone action. Hormone Research, 71(Suppl 1), 13–16.",
        "Quintos, J. B., & Vogiatzi, M. G. (2020). Environmental influences on pediatric endocrine disorders. Endocrinology and Metabolism Clinics of North America, 49(4), 669–684.",
        "Ranke, M. B. (2019). Diagnostics of endocrine growth disorders. Hormone Research in Paediatrics, 91(2), 77–90.",
        "Ranke, M. B., & Lindberg, A. (2010). Observed and predicted growth in idiopathic short stature. Hormone Research in Paediatrics, 73(4), 233–243.",
        "Ranke, M. B., & Lindberg, A. (2021). Quality of life in growth disorders: Longitudinal insights. Best Practice & Research Clinical Endocrinology & Metabolism, 35(1), 101552.",
        "Ranke, M. B., Lindberg, A., Kaspers, S., & Cutfield, W. S. (2018). Auxological decision making in pediatric endocrinology. Endocrine Development, 33, 1–12.",
        "Rosenfeld, R. G., Cohen, P., & Robison, L. L. (2019). Growth hormone and insulin-like growth factor systems. Endocrine Reviews, 40(5), 1352–1375.",
        "Sandberg, D. E., & Voss, L. D. (2018). The psychosocial consequences of short stature: A review of outcomes. Best Practice & Research Clinical Endocrinology & Metabolism, 32(4), 295–322.",
        "Savendahl, L. (2012). The effects of growth hormone therapy on quality of life. Hormone Research in Paediatrics, 78(2), 92–96.",
        "Sisley, S., Trujillo, M. V., Khoury, J., Backeljauw, P., & Gordon, C. (2013). Low frequency of pathology detection and high cost of screening in the evaluation of asymptomatic short children. Journal of Pediatrics, 163(4), 1045–1051.",
        "Stephens, A. R., & Gupta, N. (2022). Psychosocial care in pediatric endocrinology. Current Opinion in Pediatrics, 34(4), 430–436.",
        "Tencer, H., & Hughes, M. (2020). Cultural considerations in growth disorders. Journal of Pediatric Health Care, 34(5), 453–460.",
        "Thornton, P. S., Maniatis, A. K., Agha, A., & Grimberg, A. (2016). Clinical evaluation of short stature. The Journal of Pediatrics, 174, 19–25.",
        "Weaver, C. M., & Baxter, S. D. (2019). Adolescent development and health behaviors. Journal of Adolescent Health, 64(2), 127–135.",
        "Wit, J. M., Kamp, G. A., & Oostdijk, W. (2019). Towards precision medicine in growth disorders. Hormone Research in Paediatrics, 92(6), 361–373.",
    ]

    for reference in references:
        paragraph = document.add_paragraph()
        paragraph.style = document.styles["Normal"]
        paragraph.alignment = WD_ALIGN_PARAGRAPH.LEFT
        fmt = paragraph.paragraph_format
        fmt.line_spacing_rule = WD_LINE_SPACING.DOUBLE
        fmt.space_after = Pt(12)
        fmt.first_line_indent = Inches(0)
        run = paragraph.add_run(reference)
        run.font.name = "Times New Roman"
        run.font.size = Pt(12)


def main() -> None:
    """Create the ISS essay document with configured sections and references."""
    document = Document()
    configure_document(document)
    add_title_page(document)
    add_sections(document)
    add_references(document)
    document.save("Idiopathic_Short_Stature_Essay.docx")


if __name__ == "__main__":
    main()
